Recombination between polioviruses and co-circulating coxsackie A viruses: Role in the emergence of pathogenic vaccine-derived polioviruses

PLoS Pathogens

Volumn 5, Issue 5, 2009, Pages

  Jegouic, Sophie ^a   Joffret, Marie Line ^a   Blanchard, Claire ^a   Riquet, Franck B ^a   Perret, Céline ^a   Pelletier, Isabelle ^a   Colbere Garapin, Florence ^a   Rakoto Andrianarivelo, Mala ^b   Delpeyroux, Francis ^a  

^a INSTITUT PASTEUR   (France)

^b INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; OLIGONUCLEOTIDE; LIVE VACCINE; POLIOMYELITIS VACCINE;

ARTICLE; COXSACKIE VIRUS A; COXSACKIE VIRUS A17; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; MADAGASCAR; MALE; MOLECULAR CLONING; MOLECULAR EVOLUTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PHENOTYPE; PLASMID; POLIOMYELITIS; POLIOMYELITIS VIRUS; RECEPTOR GENE; RESTRICTION SITE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEMPERATURE SENSITIVITY; TRANSGENIC MOUSE; VIRUS GENOME; VIRUS INFECTION; VIRUS ISOLATION; VIRUS RECOMBINATION; VIRUS STRAIN; VIRUS VIABILITY; ANIMAL; DISEASE MODEL; DNA SEQUENCE; ENTEROVIRUS; GENETICS; PATHOLOGY; PHYLOGENY; PHYSIOLOGY; SEQUENCE ALIGNMENT; TEMPERATURE; TUMOR CELL LINE; VIROLOGY; VIRULENCE; VIRUS CULTURE; VIRUS REPLICATION;

ENTEROVIRUS; MUS MUSCULUS; POLIOVIRUS;

ANIMALS; CELL LINE, TUMOR; CLONING, MOLECULAR; DISEASE MODELS, ANIMAL; ENTEROVIRUS; FEMALE; GENOME, VIRAL; HUMANS; MADAGASCAR; MALE; MICE; MICE, TRANSGENIC; PHYLOGENY; PLAQUE ASSAY; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINES; RECOMBINATION, GENETIC; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; TEMPERATURE; VACCINES, ATTENUATED; VIRULENCE; VIRUS REPLICATION;

EID: 67249119414     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000412     Document Type: Article

References (73)

1. Minor PD (1992) The molecular biology of poliovaccines. J Gen Virol 73 (Pt 12): 3065-3077. (Pubitemid 23014156)
2. WHO (2008) Progress towards interrupting wild poliovirus transmission worldwide, January 2007-April 2008. Wkly Epidemiol Rec 83: 170-177.
3. WHO (2008) Laboratory surveillance for wild and vaccine-derived polioviruses, January 2007-June 2008. Wkly Epidemiol Rec 83: 321-328.
4. Agol VI (2006) Molecular mechanisms of poliovirus variation and evolution. Curr Top Microbiol Immunol 299: 211-259. (Pubitemid 43086566)
5. Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA (2005) Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 59: 587-635. (Pubitemid 41507443)
6. Adu F, Iber J, Bukbuk D, Gumede N, Yang SJ, et al. (2007) Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child. Virus Res 127: 17-25. (Pubitemid 46795515)
7. Estivariz CF, Watkins MA, Handoko D, Rusipah R, Deshpande J, et al. (2008) A Large Vaccine-Derived Poliovirus Outbreak on Madura Island-Indonesia, 2005. J Infect Dis 197: 347-354. (Pubitemid 351263415)
8. Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, et al. (2002) Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296: 356-359. (Pubitemid 34303692)
9. Liang X, Zhang Y, Xu W, Wen N, Zuo S, et al. (2006) An outbreak of poliomyelitis caused by type 1 vaccine-derived poliovirus in China. J Infect Dis 194: 545-551. (Pubitemid 44297837)
10. Rakoto-Andrianarivelo M, Gumede N, Jegouic S, Balanant J, Andriamamonjy SN, et al. (2008) Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar. J Infect Dis 197: 1427-1435. (Pubitemid 351706467)
11. Rousset D, Rakoto-Andrianarivelo M, Razafindratsimandresy R, Randriamanalina B, Guillot S, et al. (2003) Recombinant vaccine-derived poliovirus in Madagascar. Emerg Infect Dis 9: 885-887. (Pubitemid 36801596)
12. Shimizu H, Thorley B, Paladin FJ, Brussen KA, Stambos V, et al. (2004) Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol 78: 13512-13521. (Pubitemid 39612751)
13. Yang CF, Naguib T, Yang SJ, Nasr E, Jorba J, et al. (2003) Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol 77: 8366-8377. (Pubitemid 36871465)
14. Brown B, Oberste MS, Maher K, Pallansch MA (2003) Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region. J Virol 77: 8973-8984. (Pubitemid 36936107)
15. Pulli T, Koskimies P, Hyypia T (1995) Molecular comparison of coxsackie A virus serotypes. Virology 212: 30-38.
16. Stanway G, Brown F, Christian P, Hovi T, Hyypiä T, et al. (2005) Family Picornaviridae. In: Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA, eds (2005) Virus Taxonomy Eighth Report of the International Committee on Taxonomy of Viruses. London: Elsevier/Academic Press. pp 757-778.
17. Racaniello V (2001) Picornaviridae: the viruses and their replication. In Knipe DM, Howley PM, eds (2001) Fields Virology fourth edition. Philadelphia: Lippincott Williams and Wilkins. pp 685-722.
18. Hirst GK (1962) Genetic recombination with Newcastle disease virus, poliovirus and influenza. Cold Spring Harbor Symp Quant Biol 27: 303-308.
19. Ledinko N (1963) Genetic recombination with poliovirus type 1. Virology 20: 107-109.
20. Cuervo N, Guillot S, Romanenkova N, Combiescu M, Aubert-Combiescu A, et al. (2001) Genomic features of intertypic recombinant Sabin strains excreted by primary vaccinees. J Virol 75: 5740-5751. (Pubitemid 32553106)
21. Georgescu MM, Delpeyroux F, Tardy-Panit M, Balanant J, Combiescu M, et al. (1994) High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. J Virol 68: 8089-8101. (Pubitemid 24362698)
22. Guillot S, Caro V, Cuervo N, Korotkova E, Combiescu M, et al. (2000) Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol 74: 8434-8443. (Pubitemid 30666694)
23. Kew OM, Nottay BK, Hatch MH, Nakano JH, Obijeski JF (1981) Multiple genetic changes can occur in the oral poliovaccines upon replication in humans. J Gen Virol 56: 337-347. (Pubitemid 12221451)
24. Kirkegaard K, Baltimore D (1986) The mechanism of RNA recombination in poliovirus. Cell 47: 433-443. (Pubitemid 17210157)
25. Lindberg AM, Andersson P, Savolainen C, Mulders MN, Hovi T (2003) Evolution of the genome of Human enterovirus B: incongruence between phylogenies of the VP1 and 3CD regions indicates frequent recombination within the species. J Gen Virol 84: 1223-1235. (Pubitemid 36592615)
26. Lukashev AN, Lashkevich VA, Ivanova OE, Koroleva GA, Hinkkanen AE, et al. (2003) Recombination in circulating enteroviruses. J Virol 77: 10423-10431. (Pubitemid 37129686)
27. Rakoto-Andrianarivelo M, Guillot S, Iber J, Balanant J, Blondel B, et al. (2007) Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar. PLoS Pathog 3: e191. doi:10.1371/journal.ppat. 0030191.
28. Simmonds P, Welch J (2006) Frequency and dynamics of recombination within different species of human enteroviruses. J Virol 80: 483-493.
29. Tolskaya EA, Romanova LA, Kolesnikova MS, Agol VI (1983) Intertypic recombination in poliovirus: genetic and biochemical studies. Virology 124: 121-132. (Pubitemid 13181198)
30. Lai MMC (1992) RNA Recombination in Animal and Plant Viruses. Microbiol Rev 56: 61-79.
31. Riquet FB, Blanchard C, Jegouic S, Balanant J, Guillot S, et al. (2008) Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus. J Virol 82: 8927-8932.
32. Oberste MS, Maher K, Kilpatrick DR, Pallansch MA (1999) Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol 73: 1941-1948. (Pubitemid 29098095)
33. Caro V, Guillot S, Delpeyroux F, Crainic R (2001) Molecular strategy for 'serotyping' of human enteroviruses. J Gen Virol 82: 79-91.
34. Oberste MS, Maher K, Flemister MR, Marchetti G, Kilpatrick DR, et al. (2000) Comparison of classic and molecular approaches for the identification of untypeable enteroviruses. J Clin Microbiol 38: 1170-1174. (Pubitemid 30140578)
35. Goodfellow I, Chaudhry Y, Richardson A, Meredith J, Almond JW, et al. (2000) Identification of a cis-acting replication element within the poliovirus coding region. J Virol 74: 4590-4600. (Pubitemid 30237884)
36. Paul AV, Rieder E, Kim DW, van Boom JH, Wimmer E (2000) Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg. J Virol 74: 10359-10370. (Pubitemid 30815357)
37. Rieder E, Paul AV, Kim DW, van Boom JH, Wimmer E (2000) Genetic and biochemical studies of poliovirus cis-acting replication element cre in relation to VPg uridylylation. J Virol 74: 10371-10380. (Pubitemid 30815358)
38. Newcombe NG, Andersson P, Johansson ES, Au GG, Lindberg AM, et al. (2003) Cellular receptor interactions of C-cluster human group A coxsackieviruses. J Gen Virol 84: 3041-3050. (Pubitemid 37336788)
39. Shafren DR, Dorahy DJ, Ingham RA, Burns GF, Barry RD (1997) Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. J Virol 71: 4736-4743. (Pubitemid 27204166)
40. Wellicome SM, Thornhill MH, Pitzalis C, Thomas DS, Lanchbury JS, et al. (1990) A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J Immunol 144: 2558-2565. (Pubitemid 20136657)
41. Lopez M, Aoubala M, Jordier F, Isnardon D, Gomez S, et al. (1998) The human poliovirus receptor related 2 protein is a new hematopoietic/endothelial homophilic adhesion molecule. Blood 92: 4602-4611. (Pubitemid 29005862)
42. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, et al. (1999) Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73: 152-160. (Pubitemid 28565356)
43. Salminen MO, Carr JK, Burke DS, McCutchan FE (1995) Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses 11: 1423-1425.
44. Cherkasova EA, Yakovenko ML, Rezapkin GV, Korotkova EA, Ivanova OE, et al. (2005) Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine. J Virol 79: 1062-1070. (Pubitemid 40053890)
45. Macadam AJ, Pollard SR, Ferguson G, Dunn G, Skuce R, et al. (1991) The 5′ noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity. Virology 181: 451-458.
46. Macadam AJ, Pollard SR, Ferguson G, Skuce R, Wood D, et al. (1993) Genetic basis of attenuation of the Sabin type-2 vaccine strain of poliovirus in primates. Virology 192: 18-26. (Pubitemid 23213222)
47. Ren R, Moss EG, Racaniello VR (1991) Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J Virol 65: 1377-1382.
48. Horie H, Koike S, Kurata T, Sato-Yoshida Y, Ise I, et al. (1994) Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence. J Virol 68: 681-688. (Pubitemid 24022169)
49. Nagata N, Iwasaki T, Ami Y, Sato Y, Hatano I, et al. (2004) A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21. Virology 321: 87-100. (Pubitemid 38368106)
50. Shulman LM, Manor Y, Handsher R, Delpeyroux F, McDonough MJ, et al. (2000) Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel. J Clin Microbiol 38: 3729-3734. (Pubitemid 30768444)
51. Arita M, Shimizu H, Nagata N, Ami Y, Suzaki Y, et al. (2005) Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J Gen Virol 86: 1391-1401. (Pubitemid 40613257)
52. Georgescu MM, Tardy-Panit M, Guillot S, Crainic R, Delpeyroux F (1995) Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus. J Virol 69: 5278-5286.
53. Merkle I, van Ooij MJ, van Kuppeveld FJ, Glaudemans DH, Galama JM, et al. (2002) Biological significance of a human enterovirus B-specific RNA element in the 3′ nontranslated region. J Virol 76: 9900-9909. (Pubitemid 35006529)
54. Tardy-Panit M, Blondel B, Martin A, Tekaia F, Horaud F, et al. (1993) A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice. J Virol 67: 4630-4638. (Pubitemid 23215942)
55. Vignuzzi M, Stone JK, Arnold JJ, Cameron CE, Andino R (2006) Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439: 344-348. (Pubitemid 43128860)
56. Arita M, Zhu SL, Yoshida H, Yoneyama T, Miyamura T, et al. (2005) A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region. J Virol 79: 12650-12657. (Pubitemid 41433184)
57. Santti J, Hyypia T, Kinnunen L, Salminen M (1999) Evidence of recombination among enteroviruses. J Virol 73: 8741-8749. (Pubitemid 29441739)
58. Jiang P, Faase JA, Toyoda H, Paul A, Wimmer E, et al. (2007) Evidence for emergence of diverse polioviruses from C-cluster coxsackie A viruses and implications for global poliovirus eradication. Proc Natl Acad Sci U S A 104: 9457-9462. (Pubitemid 47185801)
59. Mendelsohn CL, Wimmer E, Racaniello VR (1989) Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56: 855-865. (Pubitemid 19082521)
60. Greve JM, Davis G, Meyer AM, Forte CP, Yost SC, et al. (1989) The major human rhinovirus receptor is ICAM-1. Cell 56: 839-847. (Pubitemid 19082519)
61. Melnick JL (1996) Enteroviruses : Polioviruses, Coxsackieviruses, Echoviruses, and Newer Enteroviruses. In: Fields DMK BN, Howley PM, Channock RM, Melnick JL, Monath TP, Roizman B, Straus SE, eds (1996) Fields Virology, third edition. Philadelphia: Lippincott -Raven Publishers. pp 655-712.
62. Chevaliez S, Szendroi A, Caro V, Balanant J, Guillot S, et al. (2004) Molecular comparison of echovirus 11 strains circulating in Europe during an epidemic of multisystem hemorrhagic disease of infants indicates that evolution generally occurs by recombination. Virology 325: 56-70. (Pubitemid 38844770)
63. Oprisan G, Combiescu M, Guillot S, Caro V, Combiescu A, et al. (2002) Natural genetic recombination between co-circulating heterotypic enteroviruses. J Gen Virol 83: 2193-2200. (Pubitemid 34993725)
64. Bessaud M, Jegouic S, Joffret ML, Barge C, Balanant J, et al. (2008) Characterization of the genome of human enteroviruses: design of generic primers for amplification and sequencing of different regions of the viral genome. J Virol Methods 149: 277-284.
65. Strimmer K, von Haeseler A (1996) Quartet Puzzling: A quartet Maximum-Likelihood Method for Reconstructing Tree Topologies. Mol Biol Evol 13: 964-969. (Pubitemid 26284912)
66. Hasegawa M, Kishino H, Yano T, Flemister MR, Pallansch MA (1985) Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol 22: 160-174. (Pubitemid 16227864)
67. Felsenstein J (2000) PHYLIP : phylogeny inference package, version 3.6a3 (computer program). Distributed by the author. Seattle: Department of Genetics, University of Washington.
68. Perriere G, Gouy M (1996) WWW-query: an on-line retrieval system for biological sequence banks. Biochimie 78: 364-369. (Pubitemid 26394644)
69. Zuker M, Mathews D, Turner D (1999) Algorithms and Thermodynamics for RNA Secondary Structure Prediction. A Practical Guide in RNA Biochemistry and Biotechnology Barciszewski J, Clark BFC, eds. NATO ASI Series, Kluwer Academic Publishers.
70. Matrosovich M, Matrosovich T, Garten W, Klenk HD (2006) New low-viscosity overlay medium for viral plaque assays. Virol J 3: 63. (Pubitemid 44395208)
71. Reed LJ, Muench M (1938) A simple method for estimating fifty percent endpoints. Amer J Hyg 27: 493-497.
72. Pizzi M (1950) Sampling variation of the fifty percent end-point, determined by the Reed-Muench (Behrens) method. Hum Biol 22: 151-190.
73. Minor PD, Pipkin PA, Hockley D, Schild GC, Almond JW (1984) Monoclonal antibodies which block cellular receptors of poliovirus. Virus Res 1: 203-212. (Pubitemid 14082517)